Total Payments
$721,138
2024 Payments
$149,065
Companies
24
Transactions
989
Medicare Patients
1,225
Medicare Billing
$267,802
Payment Breakdown by Category
Other$600,780 (83.3%)
Travel$53,364 (7.4%)
Consulting$43,383 (6.0%)
Food & Beverage$23,347 (3.2%)
Gifts$157.50 (0.0%)
Education$107.97 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $600,780 | 280 | 83.3% |
| Travel and Lodging | $53,364 | 221 | 7.4% |
| Consulting Fee | $43,383 | 19 | 6.0% |
| Food and Beverage | $23,347 | 461 | 3.2% |
| Gift | $157.50 | 3 | 0.0% |
| Education | $107.97 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $422,110 | 542 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $146,585 | 201 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $137,138 | 152 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $7,020 | 13 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $6,956 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $338.47 | 18 | $0 (2023) |
| Allergan, Inc. | $239.78 | 8 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $141.02 | 2 | $0 (2018) |
| ABBVIE INC. | $110.91 | 5 | $0 (2024) |
| Lundbeck LLC | $97.56 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149,065 | 200 | Teva Pharmaceuticals USA, Inc. ($72,622) |
| 2023 | $173,928 | 227 | Teva Pharmaceuticals USA, Inc. ($61,500) |
| 2022 | $58,632 | 86 | Alkermes, Inc. ($31,490) |
| 2021 | $49,235 | 64 | Alkermes, Inc. ($26,410) |
| 2020 | $29,722 | 55 | Alkermes, Inc. ($23,896) |
| 2019 | $121,134 | 159 | Alkermes, Inc. ($114,314) |
| 2018 | $72,975 | 107 | Alkermes, Inc. ($72,413) |
| 2017 | $66,448 | 91 | Alkermes, Inc. ($66,307) |
All Payment Transactions
989 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,984.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/20/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: CNS | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $69.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $30.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $29.48 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $7.75 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $8.44 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REJOYN (Device) | Food and Beverage | In-kind items and services | $80.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $114.18 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $9.11 | General |
| Category: Neurology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.32 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $382.15 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $205.85 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $121.16 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: CNS | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $6.12 | General |
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,420.00 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,564.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,592.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $430.92 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Travel and Lodging | Cash or cash equivalent | $145.86 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $106.84 | General |
| Category: CNS | ||||||
| 11/08/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Travel and Lodging | In-kind items and services | $330.78 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 163 | 494 | $75,035 | $30,348 |
| 2022 | 6 | 268 | 824 | $128,895 | $56,667 |
| 2021 | 6 | 359 | 1,215 | $194,020 | $83,208 |
| 2020 | 6 | 435 | 1,436 | $227,505 | $97,578 |
Total Patients
1,225
Total Services
3,969
Medicare Billing
$267,802
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 147 | $22,050 | $9,275 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 109 | $17,410 | $6,886 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 130 | $15,635 | $5,670 | 36.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 42 | $7,350 | $3,549 | 48.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 22 | $6,550 | $2,558 | 39.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 21 | 23 | $4,025 | $1,500 | 37.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 12 | 21 | $2,015 | $909.91 | 45.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 210 | $36,750 | $17,236 | 46.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 214 | $32,100 | $12,301 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 143 | $18,590 | $9,931 | 53.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 54 | $16,200 | $8,026 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 158 | $17,380 | $6,556 | 37.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 41 | 45 | $7,875 | $2,617 | 33.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 79 | 630 | $94,500 | $36,963 | 39.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 78 | 93 | $27,900 | $14,782 | 53.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 46 | 150 | $26,250 | $12,704 | 48.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 157 | $17,270 | $7,004 | 40.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 95 | $12,350 | $6,423 | 52.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 75 | 90 | $15,750 | $5,332 | 33.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 92 | 772 | $115,800 | $46,278 | 40.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 94 | 110 | $33,000 | $18,175 | 55.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 55 | 125 | $21,875 | $10,814 | 49.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 144 | $18,720 | $8,912 | 47.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 181 | $19,910 | $7,079 | 35.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 90 | 104 | $18,200 | $6,321 | 34.7% |
About Frank Chen, MD PA
Frank Chen, MD PA is a Psychiatry healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932294584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frank Chen, MD PA has received a total of $721,138 in payments from pharmaceutical and medical device companies, with $149,065 received in 2024. These payments were reported across 989 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($600,780).
As a Medicare-enrolled provider, Chen has provided services to 1,225 Medicare beneficiaries, totaling 3,969 services with total Medicare billing of $267,802. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Houston, TX
- Active Since 10/03/2006
- Last Updated 05/11/2017
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1932294584
Products in Payments
- ARISTADA (Drug) $192,218
- Aristada 441 mg (Drug) $132,913
- UZEDY (Drug) $132,823
- LYBALVI (Drug) $89,488
- ABILIFY MYCITE (Drug) $63,859
- ABILIFY MAINTENA (Drug) $61,264
- ABILIFY ASIMTUFII (Drug) $28,115
- COBENFY (Drug) $5,900
- Vivitrol 380 mg (Drug) $408.92
- INVEGA SUSTENNA (Drug) $320.94
- VRAYLAR (Drug) $310.69
- REXULTI (Drug) $247.94
- LATUDA (Drug) $141.02
- REJOYN (Device) $80.83
- SUBLOCADE (Drug) $53.46
- Auvelity (Drug) $42.67
- VIIBRYD (Drug) $40.00
- PERSERIS (Drug) $30.55
- Dyanavel XR (Drug) $30.44
- WELLBUTRIN XL (Drug) $23.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Houston
Dr. Lawrence Ginsberg, M.d, M.D
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Mazhar Khowaja
Psychiatry — Payments: $897,870
Psychiatry $897,870
Barry Gritz, M.d, M.D
Psychiatry — Payments: $731,949
Psychiatry $731,949
Dr. Aaron Peterson, Do, DO
Psychiatry — Payments: $549,804
Psychiatry $549,804
Ayesha Rashid, M.d, M.D
Psychiatry — Payments: $445,948
Psychiatry $445,948
Prashant Gajwani, Md, MD
Psychiatry — Payments: $387,789
Psychiatry $387,789